Search results
Novavax Stock (NASDAQ:NVAX): Too Much Bad News Can Fuel a Reversal
TipRanks via Yahoo Finance· 3 months agoBy most measures, investors have reason to be skeptical about vaccine specialist Novavax...
Novavax (NVAX) to Receive $350M From Canada, Stock Rises 30%
Zacks via Yahoo Finance· 9 months agoNovavax (NVAX) is set to receive $350M from the Canadian government for forfeited Covid-19 vaccine...
Could This Bullish News Make Novavax a Hot Buy?
Motley Fool· 1 year agoNovavax (NASDAQ: NVAX) is a beaten-down COVID stock that has seen its shares plummet 85% since the start of the year. For people who prefer a more...
Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?
Motley Fool via Yahoo Finance· 3 months agoNovavax (NASDAQ: NVAX) soared more than 2,700% early in the pandemic as investors bet on its ability...
Is Novavax a Buy Now?
Motley Fool via Yahoo Finance· 2 months agoNovavax (NASDAQ: NVAX) has taken investors on a roller coaster ride over the past week or so. The stock soared after the company settled a dispute with a...
Novavax Dives As Pfizer, Moderna Snag First Nods For Covid Boosters
Investor's Business Daily· 7 months agoNovavax stock crumbled Monday after the Food and Drug Administration signed off on updated Covid...
Novavax Stock Soars 25%. A Vaccine Purchase Settlement Is One Reason Why.
Barrons.com· 2 months agoNovavax was rising sharply Thursday after the vaccine maker reached a settlement with...
Is This a Good Sign for Novavax?
Motley Fool· 9 months agoNovavax (NASDAQ: NVAX) shares soared more than 30% in one trading session this week. The biotech stock has been in the doldrums ever since the company...
Novavax Stock Is Too Sickly To Buy
InvestorPlace via Yahoo Finance· 2 years agoNovavax’s Covid-19 vaccine still isn’t approved for use in the U.S. With the pandemic in full retreat and the majority of people now fully vaccinated,...
Has Novavax Just Solved Its Biggest Problem?
Motley Fool via Yahoo Finance· 2 months agoMany investors have seen Novavax (NASDAQ: NVAX) as a promising recovery story ever since the biotech launched a plan to cut costs to better match the...
